Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interim analyses in clinical trials.

S S Emerson1, T R Fleming

  • 1Epidemiology and Biometry Program, Arizona Cancer Center, Tucson.

Oncology (Williston Park, N.Y.)
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simulation study evaluating bio-creep risk in serial non-inferiority clinical trials for preservation of effect.

Statistics in biopharmaceutical research·2015
Same author

The design and conduct of clinical trials to limit missing data.

Statistics in medicine·2012
Same author

Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus.

Clinical pharmacology and therapeutics·2009
Same author

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses.

Multiple sclerosis (Houndmills, Basingstoke, England)·2008
Same author

The impact of requisition design on laboratory utilization.

American journal of clinical pathology·2002
Same author

Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches.

Statistics in medicine·2001
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Interim analyses in clinical trials are crucial for ethical and efficient cancer research. Properly accounting for these analyses prevents bias in study results.

Area of Science:

  • Clinical Research
  • Biostatistics
  • Medical Ethics

Background:

  • Clinical trials frequently involve multiple data analyses to ensure ethical conduct and research efficiency.
  • Ignoring interim analyses can lead to significant bias in study outcomes.

Purpose of the Study:

  • To discuss the role and importance of interim analyses in clinical trials.
  • To outline key considerations for planning, monitoring, and reporting studies using group sequential methods.

Main Methods:

  • Discussion of interim analyses in clinical trial design.
  • Explanation of group sequential hypothesis testing principles.
  • Consideration of ethical and logistical factors in trial monitoring.

Main Results:

Related Experiment Videos

  • Interim analyses are essential for managing ethical concerns and resource allocation in clinical trials.
  • Failure to properly implement interim analyses introduces bias, potentially compromising study validity.

Conclusions:

  • Careful planning, monitoring, and reporting of interim analyses are vital for robust clinical trial results.
  • Group sequential methods provide a framework for valid statistical inference with multiple looks at the data.